Arab Pharmaceuticals (ADCI) Net Income
Net Income
EGP 229.1M
Trailing 12 months (TTM)
As of 23 Jul 2026, 19:29 (Cairo time)
Net income is the profit remaining after all operating costs, interest and taxes are deducted from revenue — the bottom line of the income statement. A negative figure means the company recorded a loss for that fiscal year.
Net income history
| Fiscal year | Net income | YoY growth | Net margin |
|---|---|---|---|
| 2025 | 198.93M | 125.18% | 17.79% |
| 2024 | 88.35M | 24.21% | 11.25% |
| 2023 | 71.13M | -6.78% | 11.22% |
| 2022 | 76.3M | -24.76% | 15.11% |
| 2021 | 101.41M | 9.28% | 18.88% |
| 2020 | 92.8M | 115.3% | 17.82% |
| 2019 | 43.1M | 9.21% | 9.88% |
| 2018 | 39.47M | 12.39% | 10.31% |
| 2017 | 35.12M | 142.94% | 10.36% |
| 2016 | 14.45M | 209.15% | 5.78% |
| 2015 | 4.68M | 66.27% | 2.09% |
| 2014 | 2.81M | 779.33% | 1.36% |
| 2013 | 319,801.1 | -92.31% | 0.19% |
| 2012 | 4.16M | — | 2.3% |
| 2010 | 7.87M | -38.95% | 5.07% |
| 2009 | 12.89M | -27.16% | 9.05% |
| 2008 | 17.7M | -12.47% | 11.66% |
| 2007 | 20.22M | 1.72% | 13.8% |
| 2006 | 19.88M | — | 13.26% |
All monetary figures in EGP. Source: Egyptian Exchange via TradingView; annual figures from company disclosures; updated weekly. Prices refresh every 15 minutes during EGX trading hours.